博彩
Search documents
永利澳门将委任Jacqui Krum为非执行董事
Zhi Tong Cai Jing· 2025-12-04 12:03
Core Viewpoint - Wynn Macau (01128) announced the appointment of Ms. Jacqui Krum as a non-executive director, effective from January 1, 2026, while Ms. Ellen F. Whittemore's term as a non-executive director will conclude on December 31, 2025 [1] Summary by Category - **Appointments** - Ms. Jacqui Krum has been appointed as a non-executive director, effective January 1, 2026 [1] - Ms. Ellen F. Whittemore's term as a non-executive director will end on December 31, 2025 [1]
永利澳门授出485.6万份购股权
Zhi Tong Cai Jing· 2025-12-04 12:01
Core Viewpoint - Wynn Macau (01128) announced the grant of 4.856 million stock options to five independent non-executive directors under its stock option plan adopted on May 25, 2023, which will allow them to subscribe for a total of 4.856 million ordinary shares with a par value of HKD 0.001 each, pending acceptance by the grantees [1] Group 1 - The stock options granted amount to 4.856 million [1] - The stock options are part of a plan adopted on May 25, 2023 [1] - The shares have a par value of HKD 0.001 each [1] Group 2 - The grant is to five independent non-executive directors [1] - Acceptance by the grantees is required for the grant to take effect [1]
永利澳门(01128)授出485.6万份购股权
Zhi Tong Cai Jing· 2025-12-04 11:59
智通财经APP讯,永利澳门(01128)发布公告,于2025年12月4日,本公司根据其于2023年5月25日采纳的 购股权计划向五名独立非执行董事(获授人)授出485.6万份购股权,以认购本公司股本中合共485.6万股 每股面值0.001港元的普通股,惟须待获授人接纳后,方可作实。 ...
永利澳门(01128)根据雇员股份拥有计划授出奖励
Zhi Tong Cai Jing· 2025-12-04 11:56
智通财经APP讯,永利澳门(01128)发布公告,于2025年12月4日,公司根据其雇员股份拥有计划向集团 的五名雇员(选定参与者)授出奖励,以认购公司股本中合共97.13万股每股面值0.001港元的普通股(股 份),占于本公告日期公司已发行股本约0.018%,惟须待选定参与者接纳后,方可作实。 该信息由智通财经网提供 ...
永利澳门根据雇员股份拥有计划授出奖励
Zhi Tong Cai Jing· 2025-12-04 11:55
永利澳门(01128)发布公告,于2025年12月4日,公司根据其雇员股份拥有计划向集团的五名雇员(选定参 与者)授出奖励,以认购公司股本中合共97.13万股每股面值0.001港元的普通股(股份),占于本公告日期 公司已发行股本约0.018%,惟须待选定参与者接纳后,方可作实。 ...
永利澳门(01128.HK)授出合共97.13万股奖励股份
Ge Long Hui· 2025-12-04 11:52
格隆汇12月4日丨永利澳门(01128.HK)宣布,于2025年12月4日,公司根据其雇员股份拥有计划向集团的 五名雇员(「选定参与者」)授出奖励,以认购公司股本中合共971,308股每股面值0.001港元的普通股, 占本公告日期公司已发行股本约0.018%,惟须待选定参与者接纳后,方可作实。 ...
美高梅中国(02282)12月4日斥资107.44万港元回购6.36万股
智通财经网· 2025-12-04 10:32
智通财经APP讯,美高梅中国(02282)发布公告,于2025年12月4日该公司斥资107.44万港元回购6.36万 股,回购价格为每股16.8-16.99港元。 ...
港股午评:恒指涨0.19%、科指涨0.58%,科网股走势分化,机器人概念股强势爆发
Jin Rong Jie· 2025-12-04 04:20
Market Overview - The Hong Kong stock market showed mixed performance with the Hang Seng Index rising by 0.19% to 25,809.45 points, while the Hang Seng Tech Index increased by 0.58% to 5,567.23 points [1] - Major tech stocks exhibited divergent trends, with Alibaba down 0.26%, Tencent down 0.41%, and JD.com down 0.35%, while Xiaomi rose by 2.88% and Meituan increased by 2.03% [1] - The semiconductor sector saw significant gains, with InnoCare Pharma rising over 4% and the robotics sector led by Sanhua Intelligent Controls surging by 9% [1] Company News - InnoCare Pharma (02577.HK) announced a strategic cooperation agreement with Onsemi to accelerate the GaN industry ecosystem, potentially generating hundreds of millions in GaN sales in the coming years [2] - Agile Group (03383.HK) reported a pre-sale amount of approximately 8.08 billion, a year-on-year decline of 45.2% [3] - Jinke Property (01862.HK) recorded a contract sales amount of about 876 million, down 54.1% year-on-year [4] - Chint New Energy (00182.HK) is collaborating with insurance capital to establish a partnership worth 1.811 billion, aiming to promote renewable energy investments [4] - China Aluminum International (02068.HK) won a contract for a new electrolytic aluminum project valued at 3.03 billion [4] - Stone Pharmaceutical Group (01093.HK) received clinical trial approval for a selective 5-HT2A receptor agonist in the U.S. [5] - Fosun Pharma (02196.HK) obtained clinical trial approval for its subsidiary's FXS887 tablets [6] - Zai Lab (02617) had its Tazemetostat tablets included in the priority review list by the National Medical Products Administration [7] - Diligent Pharma (06996) received approval for its drug in Hong Kong for treating multiple myeloma and diffuse large B-cell lymphoma [7] - Kaisa Group (01813) postponed its liquidation hearing to December 8 [8] Institutional Insights - CCB International noted that internal demand policies are expected to drive market attention towards the upcoming "opening red" expectations, with a potential for a year-end rally in December [9] - Guotai Junan Securities indicated that the recent adjustments in the Hong Kong market may open up space for growth in 2026, with significant net inflows from southbound funds [9] - Everbright Securities highlighted that while there is considerable room for growth compared to previous bull markets, the current market may lack strong catalysts in the short term, leading to a period of consolidation [9]
港股午评:恒指涨0.19%,科技股分化,机器人概念股强势爆发
Ge Long Hui· 2025-12-04 04:04
港股三大指数盘初转跌后快速拉升回暖,恒生科技指数一度涨超1.1%,午间收涨0.58%,恒生指数、国 企指数分别上涨0.19%及0.38%。大型科技股涨跌不一,其中小米涨近3%,百度、腾讯、阿里巴巴飘 绿;据报特朗普政府力推机器人产业发展,机器人概念股爆发,龙头三花智控大涨9%;药品类股集体 拉升回暖,创新药概念股方向涨幅明显,半导体股、内银股多数活跃。另外,餐饮股、濠赌股、纸业股 普跌。(格隆汇) ...
銀河娛樂:反彈遇阻,關鍵位置如何部署?
Ge Long Hui· 2025-12-03 05:49
回顧昨日專欄【中銀做客】今天結束之前我們再聊一只剛銀河娛樂(27)。銀河娛樂的股價近期回升了一些,現在大概在40元附近,想問問這只個股目前 在市場上,是不是還是有較多資金流入,看好的人比較多呢? 中銀國際董事Niki:銀河娛樂這一兩天上漲,主要是因為市場看到了11月澳門博彩的總收入數據,高達211億元,這個數據好於市場早前的預 期。大家覺得11月並不是特別的假期旺季,10月有黃金周,12月可能有年底休假、農曆新年假期或者聖誕假期,而11月的數據都這麼好,所以對 接下來的12月以及明年1月的消費都充滿期待。整體來看,澳門板塊可能受到提振內需的影響,大家選擇的旅遊目的地近期可能會有所改變,更 多人可能會選擇澳門,所以相關股票也受到了一定的帶動和支持,大家不妨留意一下澳門博彩板塊。銀河娛樂(27)的認購證可以留意21991, 行使價50.05元,明年4月中到期,槓桿大概8倍;認沽證可以參考22044,行使價28.98元,明年5月中到期,槓桿大概7倍。 Simon:大家可以看到,以銀河娛樂(27)為例,中銀國際的產品既有認沽證也有認購證,無論投資者看好上漲還是下跌,都有相應的選擇,給 大家做參考。從技術信號總結來看, ...